| VIVESTO AB SK-,10 |
| Schweden |
| Gesundheit |
| SE0000722365 / 509722 |
| OMAX (Frankfurt) |
| FRA:OMAX, ETR:OMAX, OMAX:GR |
| - |
| https://www.vivesto.com/ |
|
Vivesto AB is a biotechnology company specializing in the development and commercialization of innovative, patient-centric cancer therapies. With a focus on advancing proprietary drug delivery systems, Vivesto AB aims to improve the effectiveness and..
>Volltext.. |
| 7.72 Mio. EUR |
| 8.73 Mio. EUR |
| - |
| -3.05 Mio. EUR |
| -3.19 Mio. EUR |
| -0.01 EUR |
| 1.22 Mio. EUR |
| 0.19 Mio. EUR |
| -3.18 Mio. EUR |
| 0.09 |
| - |
| 9.15% |
| - |
| - |
| - |
| - |
| VIVESTO |
| 05.04.26 |
|